RIO Chief Investigator Prof Sarah Fidler and Protocol Co-Chair Prof John Frater interviewed. 17 November 2021 A woman from Argentina appears to have rid herself of HIV without drugs or treatment – the second documented case of its kind in the world. Doctors believe the patient’s immune system cleared the virus on its own. Tests […]
RIO Patient Representative, Mr Simon Collins, wins biennial EACS Award
Simon Collins was the joint award winner at the 18th European AIDS Conference held on the 27th – 30th October 2021. “The [opening] ceremony ended with the presentation of the biennial EACS Award in recognition of an individual’s longstanding, impactful and sustained professional contribution to the field of HIV. In 2021 a joint award was […]
RIO trial represented at EACS 2021
The 18th European AIDS Conference (EACS) took place on the 27th – 30th of October 2021 both in London and online. From the RIO study team, Professors Sarah Fidler, Marina Caskey and John Frater and our Patient Representative Mr Simon Collins were part of the scientific programme of the conference. Prof Fidler chaired a session […]
RIO trial opens for recruitment
The RIO clinical trial will test whether a new type of therapy can keep HIV under control without daily antiretroviral treatment (ART) tablets. The novel therapy uses a combination of two experimental antibodies (called broadly neutralising monoclonal antibodies, or bNAbs) which have been designed by scientists at the Rockefeller University to target multiple strains of […]
RIO trial protocol preprint available on Research Square
Read about our #RIOtrial protocol, and the benefits of early and integrated community involvement during study design. […]
